Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates

Agios Pharmaceuticals (AGIO) came out with quarterly earnings of $4.20 per share, missing the Zacks Consensus Estimate of$ 16.69 per share. This compares to loss of $1.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -74.84%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.58 per share when it actually produced a loss of $1.69, delivering a surprise of -6.96%.Over the last four quar ...